glp-1 drugs for prediabetes Medications: Everything You Need to Know What are GLP-1 Medications and
Description
A number of studies dedicated to GLP-1RA efficacy in T2D included patients with chronic HF (CHF) (16.2% in the EXSCEL trial, 23.6% in SUSTAIN-6, 12.2% in PIONEER, 8.6% in REWIND, 20% in Harmony, 22% in ELIXA and 18% in LEADER)
Consequently, once-daily subcutaneous administration of liraglutide 3.0 mg was developed for the treatment of obesity [21] and once-weekly subcutaneous administration of semaglutide 2.4 mg is currently being investigated in phase III trials for this indication [22]
Abbasi J
IIa study.
While the data are in aggregate and deidentified, the built-in analytics of the database enable cohort selection and matching, analysis of the incidence and prevalence of events within a cohort, and comparison of characteristics and outcomes between matched cohorts
It is expected that early combination therapy modifies the natural history of the disease
